首頁 › 卵巢癌 › 紐澤西

紐澤西的卵巢癌臨床試驗

40 項針對卵巢癌的研究正在紐澤西各地點尋找參與者。

紐澤西的城市

官方研究文本（英文）

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

Memorial Sloan Kettering Basking Ridge, Basking Ridge
Memorial Sloan Kettering Monmouth, Middletown
Memorial Sloan Kettering Bergen, Montvale
還有 1 項

招募中2/3 期

18 歲及以上 · 所有性別 · 更新於 2026年10月5日 · NCT07001748

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Hunterdon Medical Center, Flemington
Monmouth Medical Center Southern Campus, Lakewood
Cooperman Barnabas Medical Center, Livingston
還有 6 項

招募中2 期

所有年齡 · 所有性別 · 更新於 2026年10月5日 · NCT05564377

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

START New Jersey, East Brunswick

招募中1 期

18 歲及以上 · 所有性別 · 更新於 2026年10月2日 · NCT06270706

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

John Theurer Cancer Center at Hackensack UMC, Hackensack

招募中1 期

19 歲及以上 · 所有性別 · 更新於 2026年10月1日 · NCT06586957

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

Holy Name Medical Center /ID# 279017, Teaneck

招募中2 期

18 歲及以上 · 女性 · 更新於 2026年10月1日 · NCT07024784

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Research Site, New Brunswick

招募中1 期

18 歲及以上 · 所有性別 · 更新於 2026年9月29日 · NCT05877599

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

John Theurer Cancer Center /ID# 275756, Hackensack
Rutgers Cancer Institute of New Jersey /ID# 274358, New Brunswick
Holy Name Medical Center /ID# 276240, Teaneck

招募中2 期

18 歲及以上 · 女性 · 更新於 2026年9月29日 · NCT06890338

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Research Site, East Brunswick

招募中2 期

18 至 130 歲 · 所有性別 · 更新於 2026年9月23日 · NCT05489211

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

Md Anderson Cancer Center At Cooper /ID# 278390, Camden

招募中2 期

18 歲及以上 · 女性 · 更新於 2026年9月22日 · NCT07059845

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Maimonides Medical Center, Short Hills

招募中3 期

18 歲及以上 · 女性 · 更新於 2026年9月15日 · NCT07214779

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

John Theurer Cancer Center, Hackensack University Medical Center, Hackensack

招募中2 期

18 至 99 歲 · 女性 · 更新於 2026年9月15日 · NCT07023627

A Study of Isoquercetin in People With Ovarian Cancer

Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale

招募中2 期

18 歲及以上 · 所有性別 · 更新於 2026年9月15日 · NCT07303894

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Astera Cancer Care, East Brunswick

招募中觀察性研究

18 歲及以上 · 所有性別 · 更新於 2026年9月14日 · NCT05059444

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

START New Jersey East Brunswick, East Brunswick

招募中1/2 期

18 歲及以上 · 所有性別 · 更新於 2026年9月14日 · NCT06303505

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

START - New Jersey, East Brunswick

招募中1 期

18 歲及以上 · 所有性別 · 更新於 2026年9月10日 · NCT06293898

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

John Theurer Cancer Center at Hackensack University Medical Center ( Site 0081), Hackensack
Rutgers Cancer Institute of New Jersey ( Site 0071), New Brunswick

招募中3 期

18 歲及以上 · 女性 · 更新於 2026年9月3日 · NCT06824467

Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer

Start Njeb, East Brunswick

招募中1/2 期

18 歲及以上 · 女性 · 更新於 2026年9月1日 · NCT07736937

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

The John Theruer Cancer Center at Hackensack University Medical Center, Hackensack

招募中1 期

15 歲及以上 · 所有性別 · 更新於 2026年8月25日 · NCT06276491

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

John Theurer Cancer Ctr at Hackensack Univ. Med Ctr., Hackensack

招募中1 期

18 歲及以上 · 所有性別 · 更新於 2026年8月21日 · NCT06774963

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Normunity Investigational Site, Hackensack

招募中1 期

18 歲及以上 · 所有性別 · 更新於 2026年8月18日 · NCT07182149

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

John Theurer Cancer Center, Hackensack

招募中1/2 期

18 歲及以上 · 所有性別 · 更新於 2026年8月17日 · NCT04895709

A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression

Site 0111, Camden

招募中3 期

18 歲及以上 · 女性 · 更新於 2026年8月12日 · NCT07546500

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Memorial Sloan Kettering Basking Ridge, Basking Ridge
Cooper Hospital University Medical Center, Camden
Jersey City Medical Center, Jersey City
還有 12 項

招募中

35 至 50 歲 · 女性 · 更新於 2026年8月7日 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Memorial Sloan Kettering Basking Ridge, Basking Ridge
Summit Medical Group, Berkeley Heights
Cooper Hospital University Medical Center, Camden
還有 9 項

招募中3 期

18 歲及以上 · 所有性別 · 更新於 2026年8月7日 · NCT06580314

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

Hackensack University Medical Center - John Theurer Cancer Center, Hackensack

招募中1 期

18 歲及以上 · 所有性別 · 更新於 2026年8月5日 · NCT07444814

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

MD Anderson Cancer Center at Cooper- Two Cooper Plaza, Camden

招募中1/2 期

18 歲及以上 · 所有性別 · 更新於 2026年8月4日 · NCT05579366

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Valley Health System, Paramus
Holy Name, Teaneck

招募中2/3 期

18 歲及以上 · 所有性別 · 更新於 2026年7月28日 · NCT06161025

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Overlook Medical Center, Summit

招募中2 期

8 歲及以上 · 所有性別 · 更新於 2026年7月27日 · NCT05503797

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

Valley Health System, Paramus

招募中3 期

18 歲及以上 · 女性 · 更新於 2026年7月2日 · NCT06819007

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

招募中

18 歲及以上 · 女性 · 更新於 2026年7月1日 · NCT05429970

A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

GSK Investigational Site, Morristown

招募中2 期

18 歲及以上 · 所有性別 · 更新於 2026年6月24日 · NCT04641247

Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women

Carol G. Simon Cancer Center / Atlantic Health, Morristown

招募中歡迎健康志工

50 至 74 歲 · 女性 · 更新於 2026年5月6日 · NCT00539162

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Holy Name Medical Center, Teaneck

招募中3 期

18 歲及以上 · 女性 · 更新於 2026年4月16日 · NCT05659381

Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery

Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale

招募中2 期

18 歲及以上 · 所有性別 · 更新於 2026年4月1日 · NCT06290193

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Hackensack University Medical Center, Hackensack

招募中1 期

18 歲及以上 · 所有性別 · 更新於 2026年2月13日 · NCT06778863

A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

招募中1 期

18 歲及以上 · 所有性別 · 更新於 2026年2月11日 · NCT06623396